Preferred Label : Bortezomib/Dexamethasone/Isatuximab/Lenalidomide Regimen;
NCIt synonyms : RVD Regimen Plus Isatuximab; RVd Plus Sarclisa; Bortezomib/Dexamethasone/Isatuximab/Lenalidomide; Bortezomib/Dexamethasone/Isatuximab-irfc/Lenalidomide; Bortezomib-Dexamethasone-Isatuximab-Lenalidomide; Sarclisa-RVd; RVD Regimen Plus Isatuximab-irfc;
NCIt related terms : Isa-RVd;
NCIt definition : A regimen consisting of bortezomib, dexamethasone, isatuximab and lenalidomide that
may be used for the treatment of multiple myeloma.;
NCI Metathesaurus CUI : CL1927712;
Codes from synonyms : 109344;
Origin ID : C205498;
chemotherapy_regimen_has_component
- concept_is_in_subset
https://ansm.sante.fr/tableau-acces-derogatoire/sarclisa
2024
false
false
false
France
French
drug information
infusions, intravenous
isatuximab
antineoplastic combined chemotherapy protocols
multiple myeloma
Bortezomib/Dexamethasone/Isatuximab/Lenalidomide Regimen
---
https://www.has-sante.fr/jcms/p_3554633/fr/sarclisa-isatuximab-myelome-multiple
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
antineoplastic combined chemotherapy protocols
Bortezomib/Dexamethasone/Isatuximab/Lenalidomide Regimen
adult
infusions, intravenous
Antineoplastic Agents, Immunological
isatuximab
evaluation of the transparency committee
multiple myeloma
isatuximab
---
